World Report "Pharma Plant Markets 2020"
World Market Report for Plants, Machinery, Electrical Equipment, Engineering and Services in the Pharmaceutical Industries. This World Report analyzes and forecasts the development for plant-related products and services in the pharma industries. Years covered: 2010, 2015, 2020.
Solid Growth Expected for Pharmaceutical Plant, Engineering and Services Markets
According to the INTECHNO World Report "Pharma Plant Markets 2020", the global market for plant-related products and external (open-market) services for the pharmaceutical industry is predicted to grow from EUR 28.9 billion in 2010 to EUR 38.3 billion in 2015 and continue to grow to EUR 52.7 billion by 2020. This is equivalent to a compound average annual growth rate of 5.8% between 2010 and 2015 and of 6.6% between 2015 and 2020. For the entire forecasting period, the compound average annual growth rate is predicted to be 6.2%. These market figures take into account changing currency exchange rates over the forecast period.
Global market size and growth for pharmaceutical plants, equipment, software and services are determined by growing global capital expenditures and rising operating expenditures during the whole lifecycle of all pharmaceutical plants installed and operating worldwide.
Due to steady progress in innovative drugs, the pharmaceutical industry contributes to longer and healthier lifetimes of the global population. Global growth of the pharmaceutical industry is and will continue to be stimulated by a growing world population, aging populations in developed countries and improved healthcare access in developing countries. Although the importance of traditional blockbuster drugs is expected to shrink, new biopharmaceutical drugs as well as generic drugs appear to constitute new major growth sectors. So do personalized drugs and targeted therapies. Especially oncology drugs are at the forefront of pharmaceutical research and development; high growth prospects can be expected for these drugs. Continuously rising demand for new synthetic and biopharmaceutical drugs is generating promising market opportunities for pharmaceutical plant suppliers, EPC firms, manufacturers of process and packaging machinery, electrical and automation equipment suppliers, suppliers of Manufacturing Execution Systems (MES), cleanroom and other building equipment manufacturers as well as suppliers of construction works.
Forecast of Global Pharma Plant Markets until 2020: Subdivision by Regions
2010 – EUR 28.9 Billion
2020 – EUR 52.7 Billion
Technology Trends
In biopharmaceuticals, disposable single-use bioreactors are gaining market shares from traditional stainless steel bioreactors. This will contribute to a reduction of engineering as well as reduced cleaning costs. Future innovative IT systems and solutions for the pharmaceutical industry are expected to be more flexible than today’s. Furthermore they have to deal with big data and smart data issues; cloud delivery models are on the rise, too. MES systems are getting more and more important. They enable to integrate and process data from various plant operations and are indispensable tools in managing unplanned events and changes in demand.
1. EXECUTIVE SUMMARY
1.1 Pharmaceutical Plant & Engineering Markets
1.2 Technology Trends
1.3 Strategies
2. AIM AND SCOPE, DEFINITIONS, EXCLUSIONS
2.1 Aim and Scope
2.2 Definitions and Exclusions
2.2.1 Country Definitions and their Attribution to Regions
2.2.2 Production Value, Shipments and Expenditures
2.2.3 Capital Expenditures
2.2.4 Production Investments
2.2.5 Production Project Costs
2.2.6 Production Operating Expenses
2.3 Market Segmentation of Plant-Related Products and Services
2.3.1 Segmentation by Plant Life-Cycle Phases
2.3.2 Segmentation by Plant-Related Products and Services
2.3.2.1 Overview
2.3.2.2 Overall Plant Services
2.3.2.3 Works-Specific Plant Services for Plant Equipment-Related Works
2.3.2.4 Works-Specific Plant Services for Plant Construction-Related Works
2.3.3 Segmentation by Plant Works
2.3.3.1 Overview
2.3.3.2 Manufacturing Execution Systems (MES)
2.3.3.3 Automation
2.3.3.4 Electrical Works
2.3.3.5 Mechanical Works
2.3.3.6 Civil and Structural Works
3. METHODOLOGY, ASSUMPTIONS AND SOURCES OF INFORMATION
3.1 Methodology
3.2 Important Assumptions
3.3 Sources of Information
4. PLANT MARKETS FOR THE PHARMACEUTICAL INDUSTRY: OVERVIEW
4.1 Pharmaceutical Industry - Basics
4.1.1 Scope and Definitions
4.1.2 Industry Codes of Relevance
4.1.3 Processes Involved
4.1.4 Overall Trends in the Pharmaceutical Industry
4.1.5 Stimulating Factors and Barriers for Pharmaceutical Markets
4.2 Worldwide Production Development in the Pharmaceutical Industry until 2020
4.2.1 Overview
4.2.2 Active Pharmaceutical Ingredients (APIs)
4.2.3 Pharmaceutical Preparations (excl. APIs)s
4.2.4 Therapeutic Drugs
4.2.5 Diagnostic Drugs
4.3 Worldwide Development of Capital Expenditures in the Pharmaceutical Industry until 2020
4.3.1 Overview
4.3.2 Capital Expenditures for Synthetic & Botanical Pharmaceuticals
4.3.3 Capital Expenditures for Biologic Pharmaceuticals
4.3.4 Production Investments in Pharmaceuticals
4.3.5 Production Investments by Types of Investments
4.3.6 External Project and Maintenance Expenditures by Supplier Structure
4.4 Worldwide Market Development of Plant-Related Products and Services in the Pharmaceutical Industry until 2020
4.4.1 Shares of Plant Works in Pharmaceutical Industry Project Costs
4.4.2 Plant Trends in the Pharmaceutical Industry
4.4.3 Worldwide Market Development of Plant-Related Products and Services in the Pharmaceutical Industry until 2020 - Overall Market/External Demand
4.4.4 Worldwide Market Development of Plant-Related Products and Services in the Pharmaceutical Industry until 2020 - Overall Market/External & Internal Demand
4.4.5 Worldwide Market Development of Plant-Related Products and Services in the Pharmaceutical Industry until 2020 - Segmentation by Works
4.4.6 Worldwide Market Development of MES-Related Products and Services in the Pharmaceutical Industry until 2020
4.4.7 Worldwide Market Development of Automation-Related Products and Services the Pharmaceutical Industry until 2020
4.4.8 Worldwide Market Development of Electrical Works-Related Products and Services the Pharmaceutical Industry until 2020
4.4.9 Worldwide Market Development of Mechanical Works-Related Products and Services in the Pharmaceutical Industry until 2020
4.4.10 Worldwide Market Development of Civil & Structural Works Related Products and Services in the Pharmaceutical Industry
until 2020
4.4.11 Worldwide Market Development of Overall Plant-Related Services in the Pharmaceutical Industry until 2020
4.4.12 Worldwide Market Development of Plant-Related Products and Services in the Pharmaceutical Industry until 2020: Segmentation by Subsectors
4.4.13 Worldwide Market Development of Plant-Related Products and Services in the Pharmaceutical Industry until 2020 - Segmentation by Core and Auxiliary Processes
5. PLANT MARKETS FOR FORMULATION & PACKAGING OF SYNTHETIC PATENTED DRUGS
5.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Synthetic Patented Drugs until 2020
5.3 Worldwide Market Development of Plant-Related Products and Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
5.4 Worldwide Market Development of MES Products and Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
5.5 Worldwide Market Development of Automation Products and Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
5.6 Worldwide Market Development of Electrical Works-Products and Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
5.7 Worldwide Market Development of Mechanical Works-Products and Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
5.8 Worldwide Market Development of Civil and Structural Works- Products and Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
5.9 Worldwide Market Development of Overall Plant Services for Formulation and Packaging of Synthetic Patented Drugs until 2020
5.10 Worldwide Market Development of MES Products and Services for Formulation and Packaging of Synthetic Patented Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
6. PLANT MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF SYNTHETIC PATENTED DRUGS
6.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Synthetic Patented Drugs until 2020
6.3 Worldwide Market Development of Plant-Related Products and Services for APIs of Synthetic Patented Drugs until 2020
6.4 Worldwide Market Development of MES Products and Services for APIs of Synthetic Patented Drugs until 2020
6.5 Worldwide Market Development of Automation Products and Services for APIs of Synthetic Patented Drugs until 2020
6.6 Worldwide Market Development of Electrical Works-Products and Services for APIs of Synthetic Patented Drugs until 2020
6.7 Worldwide Market Development of Mechanical Works-Products and Services for APIs of Synthetic Patented Drugs until 2020
6.8 Worldwide Market Development of Civil and Structural Works- Products and Services for APIs of Synthetic Patented Drugs until 2020
6.9 Worldwide Market Development of Overall Plant Services for APIs of Synthetic Patented Drugs until 2020
6.10 Worldwide Market Development of MES Products and Services for APIs of Synthetic Patented Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
7. PLANT MARKETS FOR FORMULATION & PACKAGING OF SYNTHETIC GENERIC DRUGS
7.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Synthetic Generic Drugs until 2020
7.3 Worldwide Market Development of Plant-Related Products and Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
7.4 Worldwide Market Development of MES Products and Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
7.5 Worldwide Market Development of Automation Products and Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
7.6 Worldwide Market Development of Electrical Works-Products and Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
7.7 Worldwide Market Development of Mechanical Works-Products and Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
7.8 Worldwide Market Development of Civil and Structural Works- Products and Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
7.9 Worldwide Market Development of Overall Plant Services for Formulation and Packaging of Synthetic Generic Drugs until 2020
7.10 Worldwide Market Development of MES Products and Services for Formulation and Packaging of Synthetic Generic Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
8. PLANT MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF SYNTHETIC GENERIC DRUGS
8.1 Worldwide Production Development of APIs for Synthetic Generic Drugs until 2020
8.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Synthetic Generic Drugs until 2020
8.3 Worldwide Market Development of Plant-Related Products and Services for APIs of Synthetic Generic Drugs until 2020
8.4 Worldwide Market Development of MES Products and Services for APIs of Synthetic Generic Drugs until 2020
8.5 Worldwide Market Development of Automation Products and Services for APIs of Synthetic Generic Drugs until 2020
8.6 Worldwide Market Development of Electrical Works-Products and Services for APIs of Synthetic Generic Drugs until 2020
8.7 Worldwide Market Development of Mechanical Works-Products and Services for APIs of Synthetic Generic Drugs until 2020
8.8 Worldwide Market Development of Civil and Structural Works- Products and Services for APIs of Synthetic Generic Drugs until 2020
8.9 Worldwide Market Development of Overall Plant Services for APIs of Synthetic Generic Drugs until 2020
8.10 Worldwide Market Development of MES Products and Services for APIs of Synthetic Generic Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
9. PLANT MARKETS FOR TRADITIONAL DIAGNOSTIC DRUGS
9.1 Worldwide Production Development of Traditional Diagnostic Drugs until 2020
9.2 Worldwide Development of Capital Expenditures and Production Investments for Traditional Diagnostic Drugs until 2020
9.3 Worldwide Market Development of Plant-Related Products and Services for Traditional Diagnostic Drugs until 2020
9.4 Worldwide Market Development of MES Products and Services for Traditional Diagnostic Drugs until 2020
9.5 Worldwide Market Development of Automation Products and Services for Traditional Diagnostic Drugs until 2020
9.6 Worldwide Market Development of Electrical Works-Products and Services for Traditional Diagnostic Drugs until 2020
9.7 Worldwide Market Development of Mechanical Works-Products and Services for Traditional Diagnostic Drugs until 2020
9.8 Worldwide Market Development of Civil and Structural Works- Products and Services for Traditional Diagnostic Drugs until 2020
9.9 Worldwide Market Development of Overall Plant Services for Traditional Diagnostic Drugs until 2020
9.10 Worldwide Market Development of MES Products and Services for Traditional Diagnostic Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
10. PLANT MARKETS FOR FORMULATION & PACKAGING OF BIOPHARMACEUTICAL PATENTED DRUGS
10.1 Worldwide Production Development of Biopharmaceutical Patented Drugs until 2020
10.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
10.3 Worldwide Market Development of Plant-Related Products and Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
10.4 Worldwide Market Development of MES Products and Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
10.5 Worldwide Market Development of Automation Products and Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020 426
10.6 Worldwide Market Development of Electrical Works-Products and Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
10.7 Worldwide Market Development of Mechanical Works-Products and Services for Formulation and Packaging of Biopharmaceutical Drugs Patented until 2020
10.8 Worldwide Market Development of Civil and Structural Works- Products and Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
10.9 Worldwide Market Development of Overall Plant Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020
10.10 Worldwide Market Development of MES Products and Services for Formulation and Packaging of Biopharmaceutical Patented Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
11. PLANT MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF BIOPHARMACEUTICAL PATENTED DRUGS
11.1 Worldwide Production Development of APIs for Biopharmaceutical Patented Drugs until 2020
11.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Biopharmaceutical Patented Drugs until 2020
11.3 Worldwide Market Development of Plant-Related Products and Services for APIs of Biopharmaceutical Patented Drugs until 2020
11.4 Worldwide Market Development of MES Products and Services for APIs of Biopharmaceutical Patented Drugs until 2020
11.5 Worldwide Market Development of Automation Products and Services for APIs of Biopharmaceutical Patented Drugs until 2020
11.6 Worldwide Market Development of Electrical Works-Products and Services for APIs of Biopharmaceutical Patented Drugs until 2020
11.7 Worldwide Market Development of Mechanical Works-Products and Services for APIs of Biopharmaceutical Patented Drugs until 2020
11.8 Worldwide Market Development of Civil and Structural Works-Products and Services for APIs of Biopharmaceutical Patented Drugs until 2020
11.9 Worldwide Market Development of Overall Plant Services for APIs of Biopharmaceutical Patented Drugs until 2020
11.10 Worldwide Market Development of MES Products and Services for APIs of Biopharmaceutical Patented Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
12. PLANT MARKETS FOR FORMULATION & PACKAGING OF BIOSIMILAR DRUGS
12.1 Worldwide Production Development of Biosimilar Drugs until 2020
12.2 Worldwide Development of Capital Expenditures and Production Investments for Formulation and Packaging of Biosimilar Drugs until 2020
12.3 Worldwide Market Development of Plant-Related Products and Services for Formulation and Packaging of Biosimilar Drugs until 2020
12.4 Worldwide Market Development of MES Products and Services for Formulation and Packaging of Biosimilar Drugs until 2020
12.5 Worldwide Market Development of Automation Products and Services for Formulation and Packaging of Biosimilar Drugs until 2020
12.6 Worldwide Market Development of Electrical Works-Products and Services for Formulation and Packaging of Biosimilar Drugs until 2020
12.7 Worldwide Market Development of Mechanical Works-Products and Services for Formulation and Packaging of Biosimilar Drugs until 2020
12.8 Worldwide Market Development of Civil and Structural Works- Products and Services for Formulation and Packaging of Biosimilar Drugs until 2020
12.9 Worldwide Market Development of Overall Plant Services for Formulation and Packaging of Biosimilar Drugs until 2020
12.10 Worldwide Market Development of MES Products and Services for Formulation and Packaging of Biosimilar Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
13. PLANT MARKETS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF BIOSIMILAR DRUGS
13.1 Worldwide Production Development of APIs for Biosimilar Drugs until 2020
13.2 Worldwide Development of Capital Expenditures and Production Investments for APIs of Biosimilar Drugs until 2020
13.3 Worldwide Market Development of Plant-Related Products and Services for APIs of Biosimilar Drugs until 2020
13.4 Worldwide Market Development of MES Products and Services for APIs of Biosimilar Drugs until 2020
13.5 Worldwide Market Development of Automation Products and Services for APIs of Biosimilar Drugs until 2020
13.6 Worldwide Market Development of Electrical Works-Products and Services for APIs of Biosimilar Drugs until 2020
13.7 Worldwide Market Development of Mechanical Works-Products and Services for APIs of Biosimilar Drugs until 2020
13.8 Worldwide Market Development of Civil and Structural Works- Products and Services for APIs of Biosimilar Drugs until 2020
13.9 Worldwide Market Development of Overall Plant Services forAPIs of Biosimilar Drugs until 2020
13.10 Worldwide Market Development of MES Products and Services for APIs of Biosimilar Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
14. PLANT MARKETS FOR MOLECULAR DIAGNOSTIC DRUGS
14.1 Worldwide Production Development of Molecular Diagnostic Drugs until 2020
14.2 Worldwide Development of Capital Expenditures and Production Investments for Molecular Diagnostic Drugs until 2020
14.3 Worldwide Market Development of Plant-Related Products and Services for Molecular Diagnostic Drugs until 2020
14.4 Worldwide Market Development of MES Products and Services for Molecular Diagnostic Drugs until 2020
14.5 Worldwide Market Development of Automation Products and Services for Molecular Diagnostic Drugs until 2020
14.6 Worldwide Market Development of Electrical Works-Products and Services for Molecular Diagnostic Drugs until 2020
14.7 Worldwide Market Development of Mechanical Works-Products and Services for Molecular Diagnostic Drugs until 2020
14.8 Worldwide Market Development of Civil and Structural Works- Products and Services for Molecular Diagnostic Drugs until 2020
14.9 Worldwide Market Development of Overall Plant Services for Molecular Diagnostic Drugs until 2020
14.10 Worldwide Market Development of MES Products and Services for Molecular Diagnostic Drugs until 2020: Segmentation by Core Processes and Auxiliary Processes
15. PLANT MARKETS FOR TRADITIONAL BIOLOGICALS
15.1 Worldwide Production Development of Traditional Biologicals until 2020
15.2 Worldwide Development of Capital Expenditures and Production Investments for Traditional Biologicals until 2020
15.3 Worldwide Market Development of Plant-Related Products and Services for Traditional Biologicals until 2020
15.4 Worldwide Market Development of MES Products and Services for Traditional Biologicals until 2020
15.5 Worldwide Market Development of Automation Products and Services for Traditional Biologicals until 2020
15.6 Worldwide Market Development of Electrical Works-Products and Services for Traditional Biologicals until 2020
15.7 Worldwide Market Development of Mechanical Works-Products and Services for Traditional Biologicals until 2020
15.8 Worldwide Market Development of Civil and Structural Works- Products and Services for Traditional Biologicals until 2020
15.9 Worldwide Market Development of Overall Plant Services for Traditional Biologicals until 2020
15.10 Worldwide Market Development of MES Products and Services for Traditional Biologicals until 2020: Segmentation by Core Processes and Auxiliary Processes
16. PLANT MARKETS FOR OUTSOURCING FIRMS OF AUXILIARY PROCESSES FOR THE PHARMACEUTICAL INDUSTRY
16.1 Basics and Definitions
16.2 Worldwide Market Development of Plant-Related Products and Services for Outsourcing Firms of Auxiliary Processes until 2020
16.3 Worldwide Market Development of MES Products and Services for Outsourcing Firms of Auxiliary Processes until 2020 720
16.4 Worldwide Market Development of Automation Products and Services for Outsourcing Firms of Auxiliary Processes until 2020
16.5 Worldwide Market Development of Electrical Works-Products and Services for Outsourcing Firms of Auxiliary Processes until 2020
16.6 Worldwide Market Development of Mechanical Works-Products and Services for Outsourcing Firms of Auxiliary Processes until 2020
16.7 Worldwide Market Development of Civil and Structural Works- Products and Services for Outsourcing Firms of Auxiliary Processes until 2020
16.8 Worldwide Market Development of Overall Plant-Related Services for Outsourcing Firms of Auxiliary Processes until 2020
16.9 Worldwide Market Development of Plant-Related Products and Services for Outsourcing Firms of Auxiliary Processes until 2020: Segmentation by Types of Auxiliary Processes
Segmentation by Plant Equipment and Services
MES:
a) MES hardware, MES software
b) MES services: planning/engineering, execution, training, maintenance, IT outsourcing, demolition
Automation:
a) Automation hardware, automation software
b) Automation services: planning/engineering, execution, training, maintenance, demolition
Electrical Works:
a) Switchgear, drives, others (cables, transformers)
b) Electrical services: planning/engineering, execution, training, maintenance, demolition
Mechanical Works:
a) Process & packaging machinery, transport & conveying equipment, others (storage tanks, piping systems, non-control valves)
b) Mechanical services: planning/engineering, execution, training, maintenance, demolition
Civil & Structural Works:
a) Construction materials, building equipment
b) Construction services: planning, execution, training, maintenance, facility management, demolition
Overall Plant Services:
Feasibility studies, conceptual planning, overall consulting, project management, process design, financial engineering, procurement, outsourcing.
Industries Covered
Segmentation of pharma plant markets and capital expenditure figures by the following pharma product sectors:
- Formulation and packaging for synthetic patented drugs
- APIs for synthetic patented drugs
- Formulation and packaging for synthetic generic drugs
- APIs for synthetic generic drugs
- Formulation and packaging for biopharmaceutical patented drugs
- APIs for biopharmaceutical patented drugs
- Formulation and packaging for biosimilar drugs
- APIs for biosimilar drugs
- Traditional biologicals
- Traditional diagnostic drugs
- Molecular diagnostic drugs
- Outsourcing firms for auxiliary processes.
Countries & Regions
* Background: The background calculations of this report are based on the analysis of 65 countries. However, only the countries/regions listed above are shown.
* Countries/regions shown in Report are:
- Western Europe: Germany, France, United Kingdom, Italy, Benelux, Scandinavia, Spain with Portugal, Rest of Western Europe
- Eastern Europe: Russia, Other Countries of the Former Soviet Union, Other Eastern European Countries including Turkey
- North America: USA, Rest of North America
- South America: Brazil, Rest of South America
- Asia Pacific: Japan, Australia, China, India, Rest of Asia Pacific
- Rest of the World.
Project versus Operation Phases
Core Processes versus Auxiliary Processes
For each pharma product sector, the automation markets are broken down into core and auxiliary processes:
- Core processes
- Packaging/filling
- Storage facilities
- Utilities
- Environmental facilities.
Methodology and Size of the Report
The methodology used to derive the global pharma plant market figures can be characterized as follows:
- It is model-based – this is necessary in order to handle the huge amount of data and the host of case distinctions concerning the various countries and pharma product sectors. By means of the model-based methodology, global pharma plant market figures can be determined and compared systematically for each industry and product sector, and traced back to their determining factors.
- It is reality-based in the sense that the results of the model are backed by expert interviews and a wealth of external statistics of the pharma industry.
- It is based on a bottom-up approach and a top-down approach at the same time, where both methods check and balance each other.
The World Report "Pharma Plant Markets 2020" is based on the analysis and forecast of worldwide capital expenditure figures, expert interviews and the analysis of more than 350 basic statistics, annual reports and trend analyses to underpin the market figures: association statistics, country statistics, various analyses on sales figures, investment figures, machinery, electrical and automation statistics as well as a host of annual reports.
Plant market figures shown in the report cover project phase markets as well as market figures for the operation phase.
